Proteomics International receives $2.0m in R&D tax incentive
Filed with ASX · · 1 page · English
Summary by 6ix AI
Proteomics International Laboratories Ltd. has announced the receipt of a significant research and development tax incentive, which has bolstered its cash reserves. The company received a rebate for eligible R&D expenditure incurred during the financial year, amounting to a substantial sum. This incentive is part of a federal program designed to support companies engaging in beneficial research activities in Australia.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Ignite Investment Summit Presentation
- PromarkerEndo Validation and Refinement Complete
- Notice of AGM Date
- Investor Presentation
- PromarkerD and PromarkerEso Commercial Rollout Update
Later from Proteomics International Laboratories
- Notice of Annual General Meeting/Proxy Form
- National Rollout of PromarkerD and PromarkerEso
- Quarterly Activities/Appendix 4C Cash Flow Report
- Proteomics International Launches Share Purchase Plan
- Proposed issue of securities - PIQ
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories